Synthesis of new quinoline derivatives as inhibitors of human tumor cells growth

Archiv der Pharmazie

Volumn 343, Issue 8, 2010, Pages 440-448

  Rashad, Aymn E ^a   El Sayed, Wael A ^a   Mohamed, Ashraf M ^b   Ali, Mamdouh M ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b JOUF UNIVERSITY   (Saudi Arabia)

Author keywords

Antitumor activity; Free radicals; Mcf 7 cells; Quinolines

Indexed keywords

2 (QUINOLIN 8 YLOXY)ETHANIMIDOHYDRAZIDE; 5 [(QUINOLIN 8 YLOXY)METHYL] 1,2 DIHYDRO 3H 1,2,4 TRIAZOL 3 ONE; 8 [(1 OXIDO 2,3 DIHYDRO 1,2,3,5 THIATRIAZOL 4 YL)METHOXY]QUINOLINE; 8 [(2H TETRAZOL 5 YL)METHOXY]QUINOLINE; 8 [[2 (BETA GLUCOPYRANOSYL) 2H TETRAZOL 5 YL]METHOXY]QUINOLINE; ARABINOSE 2 [5 [(QUINOLIN 8 YLOXY)METHYL] 2H TETRAZOL 2 YL]ACETYLHYDRAZONE; CATALASE; CISPLATIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; NITRIC OXIDE; QUINOLINE DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; FEMALE; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; QUINOLINES;

EID: 77955874984     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000002     Document Type: Article

References (37)

1. L. Hong-yu, T. M. William, R. H. Charles, J. M. Denis, et al., J. Med. Chem. 2008, 51, 2302-2306.
2. G. Venusia, C. Ignazio, C. Gianfranco, P. Vincenzo, et al., J. Med. Chem. 2006, 49, 1910-1915.
3. C. Yu-Hsun, H. Mei-Hua, W. Sheng-Hung, H. Li-Jiau, et al., J. Med. Chem. 2009, 52, 4883-4891.
4. A. Shreelekha, B. D. Vivek, A. Fakhara, D. Q. Ping, et al., J. Med. Chem. 2006, 49, 7242-7246.
5. J. Easmon, G. Pürstinger, K.-S. Thies, G. Heinisch, J. Hofmann, J. Med. Chem. 2006, 49, 6343-6350.
6. D. K. Jasna, G. Mira, S. Neda, Z. Branimir, et al., J. Med. Chem. 2003, 46, 4516-4524.
7. R. J. J. Herr, Bioorg. Med. Chem. 2002, 10, 3379-3393.
8. A. D. Bond, A. Fleming, F. Kelleher, J. McGinkley, V. Prajapati, Tetrahedron 2006, 62, 9577-9581.
9. A. O. de Souza, M. T. C. Pedrosa, J. B. Alderete, A. F. Cruz, et al., Pharmazie 2005, 60, 396-397.
10. M. D. Abel, H. T. Luu, R. G. Micetich, D. Q. Nguyen, et al., J. Heterocycl. Chem. 1996, 33, 415-420.
11. S. Rasoul-Amini, A. Khalaj, A. Shafiee, M. Daneshtalab, et al., Int. J. Cancer Res. 2006, 2, 102-108.
12. A. E. Rashad, M. I. Hegab, R. E. Abdel-Megeid, N. A. Fatahala, F. M. E. Abdel-Megeid, Eur J. Med. Chem. 2009, 44, 3285-3292.
13. A. E. Rashad, M. S. Mohamed, M. E. A. Zaki, S. S. Fatahala, Arch. Pharm. 2006, 339, 664-669.
14. W. A. El-Sayed, N. M. Fathi, W. A. Gad, E. S. H. El-Ashry, J. Carbohydr. Chem. 2008, 27, 357-372.
15. W. A. El-Sayed, A. E. Rashad, S. M. Awad, M. M. Ali, Nucleic Acids Res. 2009, 28, 261-274.
16. A. Alex, M. J. M. Francois, H. Christian, D. Marcel, et al., Eur. J. Med. Chem. 1975, 10, 463-468.
17. M. M. Ramla, M. A. Omar, A. M. El-Khamry, H. El-Diwani, Bioorg. Med. Chem. 2006, 14, 7324-7332.
18. M. T. Abdel-Aal, W. A. El-Sayed, S. M. El-Kosy, E. S. H. El-Ashry, Arch. Pharm. 2008, 341, 307-313.
19. F. J. Blanco, R. L. Ochs, H. Schwarz, M. Lotz, Am. J. Pathol. 1995, 146, 75-85.
20. L. M. Vedia, B. McDonald, B. Reep, B. Brene, et al., J. Biol. Chem. 1992, 267, 24929-24932.
21. J. J. Hibbs, R. R. Taintor, Z. Vavrin, E. M. Rachlin, Biochem. Biophys. Res. Commun. 1988, 157, 87-94.
22. M. J. Juedes, G. N. Wogan, Mutat. Res. 1996, 349, 51-61.
23. M. Lepoivre, F. Fieschi, J. Coves, L. Thelander, M. Fontecave, Biochem. Biophys. Res. Commun. 1991, 179, 442-448.
24. K. Fehsel, A. Jalowy, S. Qi, V. Burkart, et al., Diabetes 1993, 42, 496-500.
25. S. Dimmeler, A. M. Zeiher, Nitric Oxide 1997, 1, 275-281.
26. P. Bienvenu, L. Caron, D. Gasparutto, J. F. Kergonou, EXS 1992, 62, 257-265.
27. P. Huang, L. Feng, E. A. Oldham, M. J. Keating, W. Plunkett, Nature 2000, 407, 390-395.
28. D. A. Gewirtz, Biochem. Pharmacol. 1999, 57, 727-741.
29. D. T. Vistica, P. Skehan, D. Scudiero, A. Monks, et al., Cancer Res. 1991, 51, 2515-2520.
30. E. D. Paglia, W. N. Valentine, J. Lab. Clin. Med. 1967, 70, 158-169.
31. H. Aebi, in Method of enzymatic analysis, Vol. 2, Academic Press, New York 1984, pp. 673-684.
32. S. Marklund, G. Marklund, Eur. J. Biochem. 1974, 47, 469-474.
33. S. P. Wolf, Methods Enzymol. 1994, 233, 182-189.
34. D. L. Granger, R. R. Taintor, K. S. Boockvar, Methods: Companion Methods Enzymol. 1995, 7, 78.
35. G. L. Ellman, Arch. Biochem. Biophys. 1959, 82, 70-77.
36. T. Zhou, G. Zhou, W. Song, N. Eguchi, et al., Toxicology 1999, 142, 1-3.
37. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 1951, 193, 265-275.